PRME

PRIME MEDICINE INC

PRME·74168J101·US·Common Stock·Healthcare - Biotechnology-Activist

PRME (PRIME MEDICINE INC) is held by 114 institutional investors as of Q1 2026. Largest holders: Alphabet Inc. ($57.6M), BlackRock, Inc. ($29.6M), STATE STREET CORP ($22.1M). Net institutional sentiment: Mixed.

114
Holders
Avg rating(26 Elite)
$283.9M
Total Value
56% (125)
Fund Consensus
65 buying - 51 selling
PRMESmart Money Verdict
View all
Held by 114 funds
26 elite
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.3.3%Feb 17, 2026
ActivistG2GV 2019, L.P.7.5%Nov 12, 2025
ActivistFMR LLCFMR LLC3.8%Nov 5, 2025
ActivistAVARCH Venture Fund X, L.P.10.4%Aug 11, 2025
InsiderGLGV 2021 GP, L.L.C.Buy $5.0MAug 1, 2025
InsiderNRNELSEN ROBERTBuy $10.0MAug 1, 2025
InsiderALARCH Venture Partners X, LLCBuy $10.0MAug 1, 2025
InsiderALARCH Venture Partners XII, LLCBuy $10.0MAug 1, 2025
InsiderLRLiu David R.Buy $53KJun 30, 2025
InsiderLRLiu David R.Buy $45KJun 23, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
16.6M$57.6M1.4%-75.04%
0
Increased
8.5M(+2.8%)$29.6M0.0%+12.39%
30
Increased
6.3M(+24.5%)$22.1M0.0%-12.86%
35
Increased
6.2M(+16.4%)$21.7M0.2%-48.30%
39
New
4.5M$15.6M0.0%-10.64%
39
Increased
4.1M(+32.0%)$14.3M0.0%+3.47%
36
Increased
3M(+0.0%)$10.5M0.0%-28.94%
28
Decreased
2.9M(-9.4%)$10.2M0.0%-58.92%
0
Decreased
2.9M(-9.4%)$10.2M0.1%-58.86%
0
Increased
2.9M(+18.4%)$10.1M0.0%+4.33%
33
Increased
2.7M(+4.4%)$9.6M0.0%-47.14%
29
Decreased
1.8M(-18.7%)$6.2M0.0%+35.97%
0
Decreased
1.6M(-3.5%)$5.5M0.0%-4.90%
0
Decreased
1.4M(-10.2%)$4.8M0.0%-28.95%
0
Unchanged
1.2M$4.3M0.0%-32.32%
0
Decreased
970,425(-44.7%)$3.4M0.0%+5.58%
0
Decreased
917,212(-2.1%)$3.2M0.0%-43.23%
0
Increased
886,716(+5.3%)$3.1M0.0%-51.74%
28
New
862,204$3M0.0%-10.64%
36
Increased
844,154(+93.7%)$2.7M0.0%-1.03%
42

Showing 1-20 of 125

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used